Key Points
-
Cardiovascular disease (CVD) mortality in the Eastern Mediterranean region (EMR) is estimated to increase more dramatically in the next decade than in any other global region except Africa
-
CVD risk factors such as tobacco consumption, physical inactivity, depression, overweight/obesity, hypertension, and diabetes mellitus are prominent among the population living in the EMR
-
Despite the high risk factor and disease burden in the EMR, public knowledge and awareness of CVD symptoms and its risk factors are very low, leading to poor control of these risk factors
-
The treatment and management of CVD in the EMR is suboptimal, and mostly involves thrombolysis, with insufficient provision of timely revascularization
-
Secondary prevention through cost-effective strategies such as cardiac rehabilitation is limited by low availability
Abstract
The Eastern Mediterranean region (EMR) comprises 22 countries or territories spanning from Morocco in the west to Pakistan in the east, and contains a population of almost 600 million people. Like many other developing regions, the burden of disease in the EMR has shifted in the past 30 years from primarily communicable diseases to noncommunicable diseases such as cardiovascular disease (CVD). Cardiovascular mortality in the EMR, mostly attributable to ischaemic heart disease, is expected to increase more dramatically in the next decade than in any other region except Africa. The most prominent CVD risk factors in this region include tobacco consumption, physical inactivity, depression, obesity, hypertension, and diabetes mellitus. Many individuals living in the EMR are unaware of their risk factor status, and even if treated, these risk factors are often poorly controlled. Furthermore, infrequent use of emergency medical services, delays in access to care, and lack of access to cardiac catheterization affects the timely diagnosis of CVD. Treatment of CVD is also suboptimal in this region, consisting primarily of thrombolysis, with insufficient provision of timely revascularization. In this Review, we summarize what is known about CVD burden, risk factors, and treatment strategies for individuals living in the EMR. This information will hopefully aid decision-makers when devising strategies on how to improve CVD prevention and management in this region.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. About us. WHO http://www.emro.who.int/entity/about-us/index.html (2016).
Mandil, A., Chaaya, M. & Saab, D. Health status, epidemiological profile and prospects: Eastern Mediterranean region. Int. J. Epidemiol. 42, 616–626 (2013).
United Nations Development Programme. Human Development Report 2015: Work for Human Development (UNDP, 2015).
World Health Organization. EMRO: regional health observatory data repository. WHO: Regional Office for the Eastern Mediterranean http://gis.emro.who.int/EMRIMR/Factsheets.htm (2016).
Alwan, A. The United Nations political declaration on non-communicable diseases: are countries of the Eastern Mediterranean region ready to respond? East. Mediterr. Health J. 19, 757–758 (2013).
World Health Organization. Projections of mortality and causes of death, 2015 and 2030. WHO: Regional Office for the Eastern Mediterranean http://www.who.int/healthinfo/global_burden_disease/projections/en/ (2013).
World Health Organization. The Global Burden of Disease: 2004 Update (WHO, 2008).
Teo, K. et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the prospective urban rural epidemiology (PURE) study. JAMA 309, 1613–1621 (2013).
Suliman, A. The state of heart disease in Sudan. Cardiovasc. J. Afr. 22, 191–196 (2011).
Almahmeed, W. et al. Coronary artery disease in Africa and the Middle East. Ther. Clin. Risk Manag. 8, 65–72 (2012).
Al-Nozha, M. M. et al. Coronary artery disease in Saudi Arabia. Saudi Med. J. 25, 1165–1171 (2004).
Zeidan, R. K. et al. Prevalence and correlates of coronary heart disease: first population-based study in Lebanon. Vasc. Health Risk Manag. 12, 75–84 (2016).
Jafar, T. H., Qadri, Z. & Chaturvedi, N. Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men. Heart 94, 408–413 (2008).
Kark, J. D., Fink, R., Adler, B., Goldberger, N. & Goldman, S. The incidence of coronary heart disease among Palestinians and Israelis in Jerusalem. Int. J. Epidemiol. 35, 448–457 (2006).
Baccouche, H. et al. Acute coronary syndrome among patients with chest pain: prevalence, incidence and risk factors. Int. J. Cardiol. 214, 531–535 (2016).
Khalili, D. et al. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One 9, e105804 (2014).
Talaei, M., Sarrafzadegan, N., Sadeghi, M., Oveisgharan, S. & Iranipour, R. Incidence of cardiovascular diseases in an Iranian population: the Isfahan cohort study. Arch. Iran. Med. 16, 138–144 (2013).
Al-Jishi, A. & Mohan, P. Profile of stroke in Bahrain. Neurosciences 5, 30–34 (2000).
Abdul-Ghaffar, N., El-Sonbaty, M., el- Din Abdul-Baky, M., Marafie, A. & Al-Said, A. Stroke in Kuwait: a three-year prospective study. Neuroepidemiology 16, 40–47 (1996).
Hamad, A. et al. Stroke in Qatar: a one-year, hospital-based study. J. Stroke Cerebrovasc. Dis. 10, 236–241 (2001).
Al-Rajeh, S. et al. Stroke register: experience from the eastern province of Saudi Arabia. Cerebrovasc. Dis. 8, 86–89 (1998).
World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control (WHO, 2011).
Tatari, S., Soubra, L., Tamim, H., Akhras, K. & Kabbani, S. The economic impact of patients with heart failure on the Lebanese healthcare system. ESC Heart Fail. 2, 178–183 (2015).
ALZadjali, M. Heart failure — a public health issue in Oman: would heart failure program be cost effective? Univers. J. Public Health 2, 226–229 (2014).
World Health Organization. Global Status Report on Noncommunicable Diseases 2014 (WHO, 2014).
World Health Organization. Noncommunicable Diseases Country Profiles 2014 (WHO, 2014).
Kalaf, H. et al. Cardiovascular disease risk profile among young Saudi women of Al-Qassim, Saudi Arabia: a cross-sectional study. Int. J. Health Sci. (Qassim) 10, 29–37 (2016).
Traina, M., Almahmeed, W., Edris, A. & Tuzcu, E. M. Coronary heart disease in the Middle East and North Africa: current status and future goals. Curr. Atheroscler. Rep. 19, 24 (2017).
World Health Organization. World Health Statistics 2016 data visualizations dashboard: prevalence of tobacco smoking. WHO http://apps.who.int/gho/data/node.sdg.3-a-viz?lang=en (2016).
Maziak, W. et al. The global epidemiology of waterpipe smoking. Tob. Control., i3–i12 (2015).
Alshaikh, M. K., Filippidis, F. T., Baldove, J. P., Majeed, A. & Rawaf, S. Women in Saudi Arabia and the prevalence of cardiovascular risk factors: a systematic review. J. Environ. Public Health 2016, 7479357 (2016).
Memish, Z. A. et al. Obesity and associated factors — kingdom of Saudi Arabia, 2013. Prev. Chronic Dis. 11, E174 (2014).
The World Bank. Middle East and North Africa. The World Bank http://web.worldbank.org/WBSITE/EXTERNAL/COUNTRIES/MENAEXT/0,,menuPK:247619∼pagePK:146748∼piPK:146812∼theSitePK:256299,00.html (2013).
Powles, J. et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 3, e003733 (2013).
Mancia, G. et al. The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. Eur. Heart J. 38, 712–719 (2017).
World Health Organization. Global Health Observatory (GHO) data: Unhealthy diet. WHO http://www.who.int/gho/ncd/risk_factors/unhealthy_diet/en/ (2017).
El Bcheraoui, C. et al. Fruit and vegetable consumption among adults in Saudi Arabia, 2013. Nutr. Diet. Suppl. 7, 41–49 (2015).
Micha, R. et al. Global, regional and national consumption of major food groups in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys worldwide. BMJ Open 5, e008705 (2015).
Alqarni, S. M. A review of prevalence of obesity in Saudi Arabia. J. Obes. Eat Disord. 2, 25 (2016).
World Atlas. 29 Most obese countries in the world. World Atlas http://www.worldatlas.com/articles/29-most-obese-countries-in-the-world.html (2016).
Hajat, C., Harrison, O. & Shather, Z. A profile and approach to chronic disease in Abu Dhabi. Global. Health 8, 18 (2012).
Yusufali, A. et al. Opportunistic screening for CVD risk factors: the Dubai shopping for cardiovascular risk study (DISCOVERY). Glob. Heart 10, 265–272 (2015).
World Health Organization. Raised total cholesterol (≥5.0 mmol/L): data by country. WHO. http://apps.who.int/gho/data/view.main.2467?lang=en (2016).
Mokdad, A. Saudi health interview survey finds high rates of chronic diseases in the kingdom of Saudi Arabia. IHME http://www.healthdata.org/news-release/saudi-health-interview-survey-finds-high-rates-chronic-diseases-kingdom-saudi-arabia(2014)
Shahin, Y., Kapur, A. & Seita, A. Diabetes care in refugee camps: the experience of UNRWA. Diabetes Res. Clin. Pract. 108, 1–6 (2015).
International Diabetes Federation. Diabetes Atlas: Middle East and North Africa http://www.diabetesatlas.org/ (2015).
Rosengren, A. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364, 953–962 (2004).
Barth, J., Schumacher, M. & Herrmann-Lingen, C 2004 Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom. Med. 802–813 (2004).
Lichtman, J. H. et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation 129, 1350–1369 (2014).
Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 10, e1001547 (2013).
Okasha, A., Karam, E. & Okasha, T. Mental health services in the Arab world. World Psychiatry 11, 52–54 (2012).
Awad, A. & Al-Nafisi, H. Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey. BMC Publ. Health 14, 1131 (2014).
Mukattash TL et al. Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians. Int. J. Pharm. Pract. 20, 367–376 (2012).
Darawad, M. W., Alfasfos, N., Saleh, Z., Saleh, A. M. & Hamdan-Mansour, A. Predictors of delay in seeking treatment by Jordanian patients with acute coronary syndrome. Int. Emerg. Nurs. 26, 20–25 (2016).
World Health Organization. WHO STEPS instrument (core and expanded). The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS) (WHO, 2000).
World Health Organization. STEPS country reports. WHO http://www.who.int/chp/steps/reports/en/ (2017).
Bailey, C. J. & Kodack, M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int. J. Clin. Practice 65, 314–322 (2011).
Choudhry, N. K. et al. Untangling the relationship between medication adherence and post-myocardial infarction outcomes. Am. Heart J. 167, 51–58.e55 (2014).
Ikeda, N. et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull. World Health Organ. 92, 10–19C (2014).
Chow, C. et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 310, 959–968 (2013).
Arafah, M. et al. Centralized pan-Middle East survey on the undertreatment of hypercholesterolemia: results from the CEPHEUS study in Arabian Gulf countries. Angiology 65, 919–926 (2014).
Al Sifri, S. et al. Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment. PLoS One 9, e84350 (2014).
Malekzadeh, M. M. et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J. Hypertens. 31, 1364–1371 (2013).
Khdour, M., Hallak, H., Shaeen, M., Jarab, A. & Al-Shahed, Q. Prevalence, awareness, treatment and control of hypertension in the Palestinian population. J. Hum. Hypertens. 27, 623–628 (2013).
Yamout, R. Screening for cardiovascular risk in asymptomatic users of the primary health care network in Lebanon, 2012–2013. Prev. Chron. Dis. 11, 140089 (2014).
Al-Omran, M. Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action. Vasc. Health Risk Manag. 8, 349–355 (2012).
WHO. World Health organization/International Society of Hypertension (WH0/ISH) risk prediction charts (WHO, 2007).
Nour-Eldein, H., Abdelsalam, S. A., Nasr, G. M. & Abdelwahed, H. A. Global cardiovascular risk assessment by family physicians in Suez canal university-family medicine centers-Egypt. J. Family Med. Prim. Care 2, 365 (2013).
Ahmed, A. A., Alsharief, E. & Alsharief, A. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service. Diabetes Metab. Syndr. 7, 133–137 (2013).
Sibai, A. M. et al. The appropriateness of use of coronary angiography in Lebanon: implications for health policy. Health Policy Plan. 23, 210–217 (2008).
Panduranga, P., Sulaiman, K., Al-Zakwani, I., Zubaid, M. & Rashed, W. Utilization and determinants of in-hospital cardiac catheterization in patients with acute coronary syndrome from the Middle East. Angiology 61, 744–750 (2010).
Sibai, A. M., Tohme, R. A. & Saade, G. A. Coronary angiography in Lebanon: use and overuse. Int. J. Cardiol. 125, 422–424 (2008).
Bhatt, D. L. et al. Utilization of early invasive management strategies for high-risk patients with non-ST- segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 292, 2096–2104 (2004).
AlHabib, K. F. et al. Patient and system-related delays of emergency medical services use in acute ST-Elevation myocardial infarction: results from the third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps). PLoS One 11, e0147385 (2016).
Gibson, C. M. et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am. Heart J. 156, 1035–1044 (2008).
Eagle, K. A. et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur. Heart J. 29, 609–617 (2008).
Nguyen, H. L., Saczynski, J. S., Gore, J. M. & Goldberg, R. J. Age and sex differences in duration of pre-hospital delay in patients with acute myocardial infarction: a systematic review. Circ. Cardiovasc. Qual. Outcomes 3, 82–92 (2010).
Grace, S. L. et al. Presentation, delay, and contraindication to thrombolytic treatment in females and males with myocardial infarction. Womens Health Issues 13, 214–221 (2003).
AlHabib, K. F. et al. Baseline characteristics, management practices, and long-term outcomes of Middle Eastern patients in the Second Gulf Registry of Acute Coronary Events (Gulf RACE-2). Ann. Saudi Med. 32, 9–18 (2012).
Keeley, E. C., Boura, J. A. & Grines, C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361, 13–20 (2003).
Braunwald, E. et al. ACC/AHA Guidelines for the management of patients with unstable angina and non–ST-Segment elevation myocardial infarction: executive summary and recommendations. Circulation 102, 1193–1209 (2000).
Al-Zakwani, I. et al. Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East. Int. J. Clin. Pharm. 34, 445–451 (2012).
Al-Zakwani, I. et al. Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East. J. Thromb. Thrombolysis 33, 280–286 (2012).
The ACCESS Investigators. Management of acute coronary syndromes in developing countries: acute coronary events — a multinational survey of current management strategies. Am. Heart J. 162, 852–859 (2011).
Al Suwaidi, J. Acute coronary syndrome in the Middle East: the importance of registries for quality assessment and plans for improvement. Glob. Cardiol. Sci. Pract. 2013, 2–4 (2013).
Al Shammeri, O., Stafford, R. S., Alzenaidi, A., Al-Hutaly, B. & Abdulmonema, A. Quality of medical management in coronary artery disease. Ann. Saudi Med. 34, 488–493 (2014).
Wang, J. Y. et al. Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian Global Registry of Acute Coronary Events. Can. J. Cardiol. 31, 1455–1461 (2015).
Fu, Y. et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial one-year follow-up of patients without ST-segment elevation. Circulation 102, 1375–1381 (2000).
AlHabib, K. F. et al. Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: results of the Saudi project for assessment of coronary events (SPACE) registry. J. Saudi Heart Assoc. 23, 233–239 (2011).
Smith, S. C. et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation 124, 2458–2473 (2011).
Al-Zakwani, I. et al. Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: data from the gulf registry of acute coronary events. Angiology 62, 447–454 (2011).
Safwan, J. et al. Evaluation of the adherence to the discharge management for secondary prevention of acute coronary syndrome in Lebanon. J. Cardiol. Clin. Res. 5, 1097–2002 (2017).
Shehab, A. et al. Sex differences in management and outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Gulf SAFE). PLoS One 12, e0175405 (2017).
Gregory, L. et al. A prospective survey in European society of cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) pilot general registry. Europace 16, 308–319 (2014).
Mond, H. G. & Proclemer, A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 — a World Society of Arrhythmia's project. Pacing Clin. Electrophysiol. 34, 1013–1027 (2011).
Sulaiman, K. et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur. J. Heart Fail. 17, 347–384 (2015).
Nieminen, M. S. et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 27, 2725–2736 (2006).
Al Habeeb, W., Stewart, G. C. & Mudge, G. H. Management of end-stage heart failure: a perspective on the Arab Gulf states. Ann. Saudi Med. 29, 460–466 (2009).
Canver, C. C. et al. A high-volume heart transplantation center in an Islamic country. Asian Cardiovasc. Thorac. Ann. 19, 244–248 (2011).
Alsheikh-Ali, A. A. et al. Prevalence and treatment of cardiovascular risk factors in outpatients with atherothrombosis in the Middle East. Heart Asia 3, 77–81 (2011).
Kotseva, K., Wood, D., Backer, G. D. & Bacquer, D. D. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey. Eur. J. Prev. Cardiol. 20, 817–826 (2013).
Bhatt, D. L. et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295, 180–189 (2006).
Yusuf, S. et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 378, 1231–1243 (2011).
Sepehri, G., Talebizadeh, N., Mirzazadeh, A. & Mohsenbeigi, M. The patterns of antihypertensive drug prescription by cardiologists in Kerman province of Iran, 2006. Pharmacoepidemiol. Drug Saf. 17, 180–185 (2008).
Turk-Adawi, K., Sarrafzadegan, N. & Grace, S. L. Global availability of cardiac rehabilitation. Nat. Rev. Cardiol. 11, 586–596 (2014).
Balady, G. J. et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 115, 2675–2682 (2007).
Wong, W. P., Feng, J., Pwee, K. H. & Lim, J. A systematic review of economic evaluations of cardiac rehabilitation. BMC Health Serv. Res. 12, 243 (2012).
Sarrafzadegan, N. et al. Gender differences in risk factors and outcomes after cardiac rehabilitation. Acta Cardiol. 63, 763–770 (2008).
Poortaghi, S., Baghernia, A., Golzari, S., Safayian, A. & Atri, S. The effect of home-based cardiac rehabilitation program on self efficacy of patients referred to cardiac rehabilitation center. BMC Res. Notes 6, 287 (2013).
Turk-Adawi, K. I., Terzic, C., Bjarnason-Wehrens, B. & Grace, S. L. Cardiac rehabilitation in Canada and Arab countries: comparing availability and program characteristics. BMC Health Services Res. 15, 521 (2015).
Curnier, D.Y., Savage, P. D. & Ades, P. A. Geographic distribution of cardiac rehabilitation programs in the United States. J. Cardiopulm. Rehabil. 25, 80–84 (2005).
Moradi, B., Esmaeilzadeh, M., Maleki, M. & Sari, L. Factors associated with failure to complete phase ii cardiac rehabilitation: survey registry in Rajaie Cardiovascular Medical and Research Center. Int. Cardiovasc. Res. J. 5, 139–142 (2011).
Nalini, M. Outpatient cardiac rehabilitation use after coronary bypass surgery in the west of Iran. J. Cardiopulm. Rehabil. Prev. 34, 263–270 (2014).
Ali, M. et al. Factors affecting outpatient cardiac rehabilitation attendance after acute myocardial infarction and coronary revascularization — a local experience. J. Pak. Med. Assoc. 62, 347–351 (2012).
UNRWA Health Department. UNRWA annual report 2015 (UNRWA, 2016).
World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings (WHO, 2010).
Yusuf, S., Wood, D., Ralston, J. & Reddy, K. The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet 386, 399–402 (2015).
Acknowledgements
S.L.G. is supported in her work by the Toronto General & Toronto Western Hospital Foundation and the Peter Munk Cardiac Centre, University Health Network. The authors gratefully acknowledge the assistance of Ms Anfal Adawi (York University, Toronto, Canada) in collecting data. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the American Heart Association.
Author information
Authors and Affiliations
Contributions
K.T.-A., N.S., and S.L.G. researched data and wrote the article. K.T.-A., N.S., I.F., K.T., M.S., N.K.W., and S.L.G. contributed substantially to the discussion of its content. All authors contributed to reviewing and editing the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Turk-Adawi, K., Sarrafzadegan, N., Fadhil, I. et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol 15, 106–119 (2018). https://doi.org/10.1038/nrcardio.2017.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2017.138
This article is cited by
-
Evaluation of the prevalence of cardiometabolic disorders (diabetes, hypertension, and hyperlipidemia) diagnosed, undiagnosed, treated, and treatment goal in the elderly: Bushehr Elderly Health Program (BEH)
BMC Endocrine Disorders (2024)
-
Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study
BMC Cardiovascular Disorders (2024)
-
The difference between 2-hour post-challenge and fasting plasma glucose associates with the risk of cardiovascular disease in a normoglycemic population: the Tehran lipid and glucose study
Nutrition & Metabolism (2024)
-
Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS)
European Journal of Medical Research (2024)
-
The effect of telephone counseling based on Orem’s model on adherence to treatment and resilience of patients with coronary angioplasty: a randomized clinical trial
BMC Cardiovascular Disorders (2023)